West Pharmaceutical Services Files 8-K/A Amendment

Ticker: WST · Form: 8-K/A · Filed: May 12, 2025 · CIK: 105770

Sentiment: neutral

Topics: amendment, officer-changes, director-changes

TL;DR

West Pharma filed an 8-K/A on May 12th, amending details about director/officer changes and compensation from May 6th.

AI Summary

West Pharmaceutical Services, Inc. filed an 8-K/A on May 12, 2025, to amend a previous filing. The amendment pertains to Item 5.02, concerning the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing date for the earliest event reported is May 6, 2025.

Why It Matters

This amendment to a previous filing indicates updates or corrections related to the company's board of directors and executive compensation, which can signal changes in leadership or governance.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing and does not appear to disclose new material events or financial information that would inherently increase risk.

Key Players & Entities

FAQ

What specific items are being amended in this 8-K/A filing?

This 8-K/A filing amends Item 5.02, which covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported is May 6, 2025.

When was this 8-K/A form filed with the SEC?

This 8-K/A form was filed on May 12, 2025.

What is the company's principal executive office address?

The company's principal executive office address is 530 Herman O. West Drive, Exton, PA 19341-1147.

What is the SIC code for West Pharmaceutical Services, Inc.?

The Standard Industrial Classification (SIC) code for West Pharmaceutical Services, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Filing Details

This Form 8-K/A (Form 8-K/A) was filed with the SEC on May 12, 2025 regarding WEST PHARMACEUTICAL SERVICES INC (WST).

View full filing on EDGAR

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing